Bavarian Nordic A/S (BVNRY)
11.68
-0.13
(-1.08%)
USD |
OTCM |
Nov 13, 16:00
Bavarian Nordic Enterprise Value : 2.199B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 2.199B |
| November 12, 2026 | 2.228B |
| November 11, 2026 | 2.224B |
| November 10, 2026 | 2.281B |
| November 09, 2026 | 2.332B |
| November 06, 2026 | 2.265B |
| November 05, 2026 | 2.310B |
| November 04, 2026 | 2.346B |
| November 03, 2026 | 2.287B |
| November 02, 2026 | 2.381B |
| October 30, 2026 | 2.283B |
| October 29, 2026 | 2.335B |
| October 28, 2026 | 2.405B |
| October 27, 2026 | 2.434B |
| October 26, 2026 | 2.369B |
| October 23, 2026 | 2.335B |
| October 22, 2026 | 2.300B |
| October 21, 2026 | 2.305B |
| October 20, 2026 | 2.285B |
| October 19, 2026 | 2.226B |
| October 16, 2026 | 2.221B |
| October 15, 2026 | 2.247B |
| October 14, 2026 | 2.187B |
| October 13, 2026 | 2.221B |
| October 12, 2026 | 2.263B |
| Date | Value |
|---|---|
| October 09, 2026 | 2.222B |
| October 08, 2026 | 2.154B |
| October 07, 2026 | 2.066B |
| October 06, 2026 | 2.067B |
| October 05, 2026 | 2.064B |
| October 02, 2026 | 2.009B |
| October 01, 2026 | 2.003B |
| September 30, 2026 | 2.071B |
| September 29, 2026 | 2.164B |
| September 28, 2026 | 2.188B |
| September 25, 2026 | 2.175B |
| September 24, 2026 | 2.202B |
| September 23, 2026 | 2.216B |
| September 22, 2026 | 2.096B |
| September 21, 2026 | 2.096B |
| September 18, 2026 | 2.076B |
| September 17, 2026 | 2.065B |
| September 16, 2026 | 2.004B |
| September 15, 2026 | 2.039B |
| September 14, 2026 | 2.039B |
| September 11, 2026 | 2.053B |
| September 10, 2026 | 2.051B |
| September 09, 2026 | 2.049B |
| September 08, 2026 | 2.123B |
| September 04, 2026 | 2.245B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Evaxion AS | 15.96M |
| Genmab A/S | 34.93B |
| Ascendis Pharma A/S | 17.48B |
| Zealand Pharma A/S | 407.51M |
| Agenus, Inc. | 487.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 68.79M |
| Revenue (Quarterly) | 275.90M |
| Total Expenses (Quarterly) | 207.11M |
| EPS Diluted (Quarterly) | 0.305 |
| Gross Profit Margin (Quarterly) | 51.56% |
| Profit Margin (Quarterly) | 24.93% |
| Earnings Yield | 5.29% |
| Operating Earnings Yield | 6.66% |
| Normalized Earnings Yield | 5.107 |